A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
← catalyst calendarNCT06268873 · readout in 553 d
Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
Phase 3
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
2,554actual
Sites
565
Countries
Argentina, Australia, Belgium +35
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-03-29 | actual | When the study began enrolling |
| Primary completion | 2028-02-24 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-02-24 | estimated | The whole study's end, after follow-up |
| First posted | 2024-02-20 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-26 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Chronic Kidney Disease and Hypertension
Interventions
- Drug: Baxdrostat/dapagliflozin — also filed as Baxdrostat CIN-107
- Drug: Dapagliflozin in combination with placebo
Primary outcome
what the primary-completion date above is the date OFTo determine whether baxdrostat/dapagliflozin is superior to dapagliflozin alone to slow CKD progression, assessed as the effect on change in eGFR over time.
measured Baseline - 2 years + 12 weeks
Publications
- PMID 42335037 — linked by the registry
- PMID 41430169 — linked by the registry
- PMID 40913594 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed